Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 20/20 | 0.86 |
| ▸ | CNR2 | P34972 | 1/20 | 0.64 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2063407 | 0.90 | CNR1 (0.73) | CNR1CNR2KCNH2 | |
| SCHEMBL2064186 | 0.89 | CNR1 (0.87) | CNR1CNR2KCNH2 | |
| SCHEMBL2063891 | 0.89 | CNR1 (0.84) | CNR1CNR2KCNH2 | |
| SCHEMBL2063750 | 0.86 | CNR1 (0.66) | CNR1CNR2KCNH2 | |
| SCHEMBL2062975 | 0.85 | CNR1 (0.75) | CNR1CNR2KCNH2 | |
| SCHEMBL2063344 | 0.85 | CNR1 (0.86) | CNR1CNR2KCNH2 | |
| SCHEMBL2063691 | 0.85 | CNR1 (0.86) | CNR1CNR2KCNH2 | |
| SCHEMBL2063405 | 0.84 | CNR1 (0.77) | CNR1 | |
| SCHEMBL2063871 | 0.84 | CNR1 (0.80) | CNR1CNR2KCNH2 | |
| SCHEMBL2063744 | 0.84 | CNR1 (0.74) | CNR1CNR2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8148404-B2 | Modulators of CB1 receptors | 7TM PHARMA A/S (DK) | 2012-04-03 | — | — | US | disclosed |
| US-20100144701-A1 | Modulators of CB1 Receptors | 7TM PHARMA A/S (DK) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144701-A1 | Modulators of CB1 Receptors | CNR1, CNR2, GPR6 | CNR1 1/4885CNR2 2/4885KCNH2 1148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.